Beyond BMI: What a New Obesity Study Reveals

For decades, medicine has used body mass index, or BMI, as the main doorway into obesity diagnosis. BMI offers speed and simplicity, but it cannot distinguish fat from muscle. It also cannot show where fat accumulates or whether that fat has begun to affect health.

A new JAMA Network Open study adds an important practical insight. Measuring the waist may capture much of the useful information that BMI misses, without requiring a complicated set of body measurements. However, the study also reminds us that identifying excess body fat and understanding its health effects remain two different tasks.

What Did the Researchers Study?

The researchers analyzed 1,900 American adults between ages 20 and 59. Each participant had undergone a DEXA scan, which estimated total body fat and visceral fat around the organs.

The investigators compared five approaches:

• BMI alone
• Waist circumference alone
• BMI or waist circumference
• A simplified Lancet definition
• The full Lancet definition, which combines BMI, waist circumference, waist-to-height ratio, and waist-to-hip ratio

The researchers treated DEXA body-fat measurements as the reference standard. They then asked how accurately each simpler method identified people who met the study’s body-fat thresholds for obesity.

What Did the Study Find?

BMI alone performed worst. It identified only about half of the adults whom DEXA classified as having obesity. In other words, a seemingly reassuring BMI often missed excess body fat.

Waist circumference alone performed surprisingly well. Combining BMI with waist circumference produced the best overall balance between identifying obesity and avoiding incorrect diagnoses.

The full Lancet definition detected more people with excess body fat. However, it also classified more people incorrectly. Therefore, it worked well as a broad population-screening tool but offered less precision when applied to an individual patient.

Diagnostic approach	Sensitivity	Specificity	Practical meaning
BMI alone	51%	95%	Few false alarms, but missed nearly half of DEXA-defined obesity
Waist alone	71%	92%	Simple and fairly accurate
BMI or waist	74%	90%	Best overall balance in this study
Full Lancet definition	88%	71%	Found more cases, but produced more false positives

Sensitivity describes how often a method detects people who truly meet the study’s body-fat definition. Specificity describes how often it correctly reassures people who do not.

When extrapolated to the US population aged 20–59, the tradeoff became substantial. The full Lancet definition would miss fewer people, but it would produce almost three times as many false-positive classifications as the BMI-or-waist approach.

Why Does Waist Size Matter?

This study reinforces what obesity and cardiovascular medicine have increasingly recognized. Fat location may matter as much as total body size.

Abdominal fat often reflects deeper visceral fat around the liver, pancreas, intestines, and other organs. This pattern can connect with insulin resistance, fatty liver disease, high triglycerides, hypertension, inflammation, sleep apnea, and cardiovascular disease.

BMI cannot see that distribution. A muscular person may have a high BMI without excess fat, while another person may have a lower BMI but carry metabolically harmful fat around the abdomen. Waist circumference helps expose this hidden difference.

This does not make BMI useless. BMI remains an efficient starting point, especially when clinicians follow it over time. However, BMI works better as one coordinate within a larger metabolic map rather than as a complete diagnosis.

How Does This Fit With the New Lancet Framework?

The Lancet Commission proposed moving obesity diagnosis beyond BMI. It recommended confirming excess adiposity through direct body-fat testing or multiple body measurements. It also distinguished between preclinical obesity and clinical obesity.

Preclinical obesity means excess body fat exists, but it has not produced clear organ dysfunction or physical limitation. Clinical obesity means excess fat has already impaired health or daily function.

The new JAMA study tested how well different measurements detected body fat. However, it did not evaluate the second half of the Lancet framework: whether excess fat had caused illness, symptoms, or functional impairment.

That distinction matters. A tape measure may help identify abdominal fat, but it cannot measure fatty liver disease, insulin resistance, shortness of breath, joint limitations, sleep apnea, or cardiovascular risk. Therefore, the study evaluates obesity measurement more directly than it evaluates the complete clinical meaning of obesity.

Assessment	What it tells us	What it may miss
BMI	Body size relative to height	Muscle mass and fat distribution
Waist circumference	Abdominal fat pattern	Total fat, muscle, and organ effects
DEXA	Estimated fat and lean mass	Complete metabolic health and fat function
Clinical evaluation	Health consequences and treatment priorities	Requires more time and individualized judgment

What Might This Look Like in Real Patients?

The same BMI can represent very different physiology, which makes individualized interpretation essential.

• Case 1 — Normal BMI With Abdominal Fat: A 48-year-old man has a BMI of 24.8, but his waist has gradually expanded. Testing reveals rising glucose, triglycerides, blood pressure, and liver fat. BMI alone offers false reassurance, while his waist and metabolic pattern reveal the broader problem.
• Case 2 — High BMI With Greater Muscle Mass: A 35-year-old athletic woman has a BMI slightly above 30. Her waist remains modest, and her metabolic testing looks excellent. BMI overstates her body-fat burden, although continued monitoring still makes sense.
• Case 3 — Excess Fat Without Current Complications: A 42-year-old woman meets body-fat and waist criteria for obesity. However, her glucose, liver, blood pressure, sleep, and physical function remain appropriate. She may fit a preclinical pattern that calls for prevention without assuming advanced disease.
• Case 4 — Clinical Obesity Beyond the Measurement: A 56-year-old man has an elevated BMI and waist circumference alongside diabetes, fatty liver disease, sleep apnea, and limited mobility. His measurements identify excess adiposity, while his organ effects establish its clinical importance and guide treatment intensity.

What Are the Study’s Limitations?

The researchers used data from one NHANES cycle and included only adults aged 20–59. Therefore, the results may not apply equally to older adults, younger people, or every racial and ethnic group.

Waist measurements can also change depending on where and how someone places the measuring tape. The study found weaker diagnostic performance in men, suggesting that some male thresholds may need refinement.

Most importantly, DEXA-defined body-fat percentage represents a useful reference, but it does not serve as a perfect definition of disease. Body composition changes with age, sex, ethnicity, menopause, muscle mass, and other biological factors. No single body-fat threshold can fully describe every person’s health.

The Takeaway

This study does not replace BMI with a tape measure. Instead, it supports a more sensible combination: use BMI as a starting point, add waist circumference, and then interpret both within the patient’s complete metabolic and functional picture.

For routine clinical care, BMI plus a properly measured waist may offer nearly all the practical diagnostic value of more complicated measurement formulas. Yet neither number should act as judge and jury. The meaningful questions remain whether excess fat exists, where it has accumulated, how it behaves, and whether it has started to affect the body.

At our practice in Montgomery County, Maryland, and through virtual care, we evaluate obesity from multiple angles. We connect BMI and waist size with body composition, glucose regulation, liver health, blood pressure, cholesterol, sleep, muscle, medications, and daily function. This panoramic view helps transform a numerical label into personalized care and a meaningful treatment strategy.